FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945889557> ?p ?o ?g. }

• W2945889557 endingPage "1132" @default.
• W2945889557 startingPage "1117" @default.
• W2945889557 abstract "In an effort to develop a new therapy for cancer and to improve antiprogrammed death inhibitor-1 (anti-PD-1) and anticytotoxic T lymphocyte-associated protein (anti-CTLA-4) responses, we have created a telomerase reverse transcriptase promoter-regulated oncolytic adenovirus rAd.sT containing a soluble transforming growth factor receptor II fused with human IgG Fc fragment (sTGFβRIIFc) gene. Infection of breast and renal tumor cells with rAd.sT produced sTGFβRIIFc protein with dose-dependent cytotoxicity. In immunocompetent mouse 4T1 breast tumor model, intratumoral delivery of rAd.sT inhibited both tumor growth and lung metastases. rAd.sT downregulated the expression of several transforming growth factor β (TGFβ) target genes involved in tumor growth and metastases, inhibited Th2 cytokine expression, and induced Th1 cytokines and chemokines, and granzyme B and perforin expression. rAd.sT treatment also increased the percentage of CD8+ T lymphocytes, promoted the generation of CD4+ T memory cells, reduced regulatory T lymphocytes (Tregs), and reduced bone marrow-derived suppressor cells. Importantly, rAd.sT treatment increased the percentage of CD4+ T lymphocytes, and promoted differentiation and maturation of antigen-presenting dendritic cells in the spleen. In the immunocompetent mouse Renca renal tumor model, similar therapeutic effects and immune activation results were observed. In the 4T1 mammary tumor model, rAd.sT improved the inhibition of tumor growth and lung and liver metastases by anti-PD-1 and anti-CTLA-4 antibodies. Analysis of the human breast and kidney tumors showed that a significant number of tumor tissues expressed high levels of TGFβ and TGFβ-inducible genes. Therefore, rAd.sT could be a potential enhancer of anti-PD-1 and anti-CTLA-4 therapy for treating breast and kidney cancers." @default.
• W2945889557 created "2019-05-29" @default.
• W2945889557 creator A5004707957 @default.
• W2945889557 creator A5015368954 @default.
• W2945889557 creator A5019144745 @default.
• W2945889557 creator A5020370754 @default.
• W2945889557 creator A5021636467 @default.
• W2945889557 creator A5022006244 @default.
• W2945889557 creator A5022704236 @default.
• W2945889557 creator A5035893717 @default.
• W2945889557 creator A5043222296 @default.
• W2945889557 creator A5053725057 @default.
• W2945889557 creator A5056204035 @default.
• W2945889557 creator A5056458209 @default.
• W2945889557 creator A5062386238 @default.
• W2945889557 creator A5068489282 @default.
• W2945889557 creator A5074373854 @default.
• W2945889557 creator A5076282744 @default.
• W2945889557 creator A5080090747 @default.
• W2945889557 creator A5080102032 @default.
• W2945889557 creator A5086795317 @default.
• W2945889557 creator A5090830410 @default.
• W2945889557 date "2019-09-01" @default.
• W2945889557 modified "2023-10-17" @default.
• W2945889557 title "An Oncolytic Adenovirus Targeting Transforming Growth Factor β Inhibits Protumorigenic Signals and Produces Immune Activation: A Novel Approach to Enhance Anti-PD-1 and Anti-CTLA-4 Therapy" @default.
• W2945889557 cites W1139261911 @default.
• W2945889557 cites W1558523041 @default.
• W2945889557 cites W1578464769 @default.
• W2945889557 cites W1597704353 @default.
• W2945889557 cites W1700691315 @default.
• W2945889557 cites W1834835434 @default.
• W2945889557 cites W1872518637 @default.
• W2945889557 cites W1929921696 @default.
• W2945889557 cites W1983516942 @default.
• W2945889557 cites W1990466785 @default.
• W2945889557 cites W1992215859 @default.
• W2945889557 cites W1997104993 @default.
• W2945889557 cites W2000315116 @default.
• W2945889557 cites W2002894826 @default.
• W2945889557 cites W2016473084 @default.
• W2945889557 cites W2020994242 @default.
• W2945889557 cites W2023075736 @default.
• W2945889557 cites W2029187457 @default.
• W2945889557 cites W2029765161 @default.
• W2945889557 cites W2030127516 @default.
• W2945889557 cites W2031984295 @default.
• W2945889557 cites W2037951366 @default.
• W2945889557 cites W2041654067 @default.
• W2945889557 cites W2043804065 @default.
• W2945889557 cites W2049952383 @default.
• W2945889557 cites W2052131982 @default.
• W2945889557 cites W2053061663 @default.
• W2945889557 cites W2067487435 @default.
• W2945889557 cites W2067818659 @default.
• W2945889557 cites W2074604431 @default.
• W2945889557 cites W2076744099 @default.
• W2945889557 cites W2086338128 @default.
• W2945889557 cites W2089147663 @default.
• W2945889557 cites W2095463689 @default.
• W2945889557 cites W2099316577 @default.
• W2945889557 cites W2105435586 @default.
• W2945889557 cites W2111916686 @default.
• W2945889557 cites W2115852392 @default.
• W2945889557 cites W2118547009 @default.
• W2945889557 cites W2120426523 @default.
• W2945889557 cites W2130687125 @default.
• W2945889557 cites W2132413371 @default.
• W2945889557 cites W2136280424 @default.
• W2945889557 cites W2138504051 @default.
• W2945889557 cites W2142604595 @default.
• W2945889557 cites W2144010265 @default.
• W2945889557 cites W2163240418 @default.
• W2945889557 cites W2163758870 @default.
• W2945889557 cites W2165200432 @default.
• W2945889557 cites W2260659963 @default.
• W2945889557 cites W2280100400 @default.
• W2945889557 cites W2338576144 @default.
• W2945889557 cites W2395612161 @default.
• W2945889557 cites W2494461917 @default.
• W2945889557 cites W2508710837 @default.
• W2945889557 cites W2557336488 @default.
• W2945889557 cites W2560367415 @default.
• W2945889557 cites W2592102847 @default.
• W2945889557 cites W2604405073 @default.
• W2945889557 cites W2618764609 @default.
• W2945889557 cites W2620593565 @default.
• W2945889557 cites W2621295461 @default.
• W2945889557 cites W2622499649 @default.
• W2945889557 cites W2626781325 @default.
• W2945889557 cites W2785803176 @default.
• W2945889557 cites W2788975052 @default.
• W2945889557 doi "https://doi.org/10.1089/hum.2019.059" @default.
• W2945889557 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/6761593" @default.
• W2945889557 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31126191" @default.
• W2945889557 hasPublicationYear "2019" @default.
• W2945889557 type Work @default.
• W2945889557 sameAs 2945889557 @default.
• W2945889557 citedByCount "33" @default.

• next